Journal of Asthma
Volume 59, 2022 - Issue 3
Asthma Control
A structured review evaluating content validity of the Asthma Control Test, and its consistency with U.S. guidelines and patient expectations for asthma control
Linda M. Nelsena Value Evidence and Outcomes, GlaxoSmithKline plc., Collegeville, PA, USACorrespondence[email protected]
https://orcid.org/0000-0002-3929-4064View further author information
, MHShttps://orcid.org/0000-0002-3929-4064View further author information, Mark Kosinskib Optum, Johnston, RI, USA (at the time of study)https://orcid.org/0000-0003-0563-5542View further author information
, MAhttps://orcid.org/0000-0003-0563-5542View further author information, Avery A. Riziob Optum, Johnston, RI, USA (at the time of study)https://orcid.org/0000-0003-1881-4523View further author information
, PhDhttps://orcid.org/0000-0003-1881-4523View further author information, Loretta Jacquesc Clinical Sciences, GlaxoSmithKline plc., Uxbridge, MDX, UKhttps://orcid.org/0000-0001-7293-3246View further author information
, PhDhttps://orcid.org/0000-0001-7293-3246View further author information, Michael Schatzd Department of Allergy, Kaiser Permanente Medical Center, San Diego, CA, USAhttps://orcid.org/0000-0002-7640-5560View further author information
, MDhttps://orcid.org/0000-0002-7640-5560View further author information, Richard H. Stanforde US Value Evidence and Outcomes, GlaxoSmithKline plc., Research Triangle Park, NC, USA (at the time of study)https://orcid.org/0000-0001-5795-1147View further author information
, PharmDhttps://orcid.org/0000-0001-5795-1147View further author information & , PhD show all